PL3854391T3 - Związek karbaminianowy i zastosowanie preparatu zawierającego ten związek do zapobiegania, łagodzenia lub leczenia ostrego zaburzenia stresowego lub zespołu stresu pourazowego - Google Patents
Związek karbaminianowy i zastosowanie preparatu zawierającego ten związek do zapobiegania, łagodzenia lub leczenia ostrego zaburzenia stresowego lub zespołu stresu pourazowegoInfo
- Publication number
- PL3854391T3 PL3854391T3 PL19861698.9T PL19861698T PL3854391T3 PL 3854391 T3 PL3854391 T3 PL 3854391T3 PL 19861698 T PL19861698 T PL 19861698T PL 3854391 T3 PL3854391 T3 PL 3854391T3
- Authority
- PL
- Poland
- Prior art keywords
- stress disorder
- alleviating
- formulation
- post
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862734403P | 2018-09-21 | 2018-09-21 | |
| PCT/KR2019/012183 WO2020060251A1 (ko) | 2018-09-21 | 2019-09-20 | 카바메이트 화합물 및 이를 포함하는 배합물의 급성 스트레스 장애 또는 외상 후 스트레스 장애의 예방, 경감 또는 치료를 위한 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3854391T3 true PL3854391T3 (pl) | 2024-06-24 |
Family
ID=69887639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19861698.9T PL3854391T3 (pl) | 2018-09-21 | 2019-09-20 | Związek karbaminianowy i zastosowanie preparatu zawierającego ten związek do zapobiegania, łagodzenia lub leczenia ostrego zaburzenia stresowego lub zespołu stresu pourazowego |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220117941A1 (pl) |
| EP (1) | EP3854391B1 (pl) |
| JP (1) | JP7408643B2 (pl) |
| KR (1) | KR20210047888A (pl) |
| CN (1) | CN113015524B (pl) |
| AU (1) | AU2019344261B2 (pl) |
| BR (1) | BR112021005193A2 (pl) |
| CA (1) | CA3112166A1 (pl) |
| ES (1) | ES2978226T3 (pl) |
| IL (1) | IL281559B2 (pl) |
| MX (1) | MX2021003203A (pl) |
| PL (1) | PL3854391T3 (pl) |
| TW (1) | TWI856977B (pl) |
| WO (1) | WO2020060251A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR125970A1 (es) * | 2021-05-28 | 2023-08-30 | Sk Biopharmaceuticals Co Ltd | Formulaciones de suspensión acuosa para administración oral que comprenden un compuesto de carbamato |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1383489B1 (en) * | 2001-02-27 | 2007-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| CN1845730A (zh) * | 2003-09-04 | 2006-10-11 | H.隆德贝克有限公司 | 5－羟色胺再摄取抑制剂与克塞平的组合 |
| US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| WO2009015244A1 (en) * | 2007-07-23 | 2009-01-29 | Synosia Therapeutics | Rufinamide for the treatment of post-traumatic stress disorder |
| CN102803233B (zh) | 2009-06-22 | 2017-03-01 | 爱思开生物制药株式会社 | 制备氨基甲酸(r)‑1‑芳基‑2‑四唑基‑乙酯的方法 |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| KR102421006B1 (ko) * | 2016-05-19 | 2022-07-14 | 에스케이바이오팜 주식회사 | 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도 |
| KR102421013B1 (ko) * | 2016-05-19 | 2022-07-14 | 에스케이바이오팜 주식회사 | 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| KR102900173B1 (ko) * | 2016-12-14 | 2025-12-12 | 에스케이바이오팜 주식회사 | 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도 |
| WO2018111008A1 (ko) * | 2016-12-14 | 2018-06-21 | 에스케이바이오팜 주식회사 | 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| ES3039979T3 (en) * | 2016-12-14 | 2025-10-28 | Sk Biopharmaceuticals Co Ltd | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
| KR102605030B1 (ko) * | 2016-12-14 | 2023-11-23 | 에스케이바이오팜 주식회사 | 카바메이트 화합물을 포함하는 비경구용 액상 제제 |
| KR102901908B1 (ko) * | 2016-12-14 | 2025-12-17 | 에스케이바이오팜 주식회사 | 운동신경세포 질환의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
-
2019
- 2019-09-20 PL PL19861698.9T patent/PL3854391T3/pl unknown
- 2019-09-20 EP EP19861698.9A patent/EP3854391B1/en active Active
- 2019-09-20 JP JP2021516362A patent/JP7408643B2/ja active Active
- 2019-09-20 IL IL281559A patent/IL281559B2/en unknown
- 2019-09-20 ES ES19861698T patent/ES2978226T3/es active Active
- 2019-09-20 CA CA3112166A patent/CA3112166A1/en active Pending
- 2019-09-20 CN CN201980060752.8A patent/CN113015524B/zh active Active
- 2019-09-20 US US17/277,846 patent/US20220117941A1/en active Pending
- 2019-09-20 AU AU2019344261A patent/AU2019344261B2/en active Active
- 2019-09-20 KR KR1020217007239A patent/KR20210047888A/ko not_active Ceased
- 2019-09-20 MX MX2021003203A patent/MX2021003203A/es unknown
- 2019-09-20 BR BR112021005193-7A patent/BR112021005193A2/pt unknown
- 2019-09-20 TW TW108134034A patent/TWI856977B/zh active
- 2019-09-20 WO PCT/KR2019/012183 patent/WO2020060251A1/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN113015524B (zh) | 2024-09-17 |
| EP3854391B1 (en) | 2024-03-13 |
| JP2022502365A (ja) | 2022-01-11 |
| IL281559A (en) | 2021-05-31 |
| TW202024040A (zh) | 2020-07-01 |
| BR112021005193A2 (pt) | 2021-06-08 |
| EP3854391A4 (en) | 2022-06-29 |
| AU2019344261B2 (en) | 2025-03-27 |
| IL281559B1 (en) | 2025-02-01 |
| AU2019344261A1 (en) | 2021-04-08 |
| EP3854391A1 (en) | 2021-07-28 |
| US20220117941A1 (en) | 2022-04-21 |
| KR20210047888A (ko) | 2021-04-30 |
| MX2021003203A (es) | 2021-05-27 |
| TWI856977B (zh) | 2024-10-01 |
| CN113015524A (zh) | 2021-06-22 |
| WO2020060251A1 (ko) | 2020-03-26 |
| IL281559B2 (en) | 2025-06-01 |
| CA3112166A1 (en) | 2020-03-26 |
| ES2978226T3 (es) | 2024-09-09 |
| JP7408643B2 (ja) | 2024-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271503A (en) | Preparations and treatments for sleep disorders | |
| IL261932A (en) | Use of probiotics in the treatment and/or prevention of eczema | |
| IL256231A (en) | History Diaryl and arylheteroaryl ureas are useful for the prevention and treatment of rem sleep behavior disorder | |
| ZA201900044B (en) | Tuberculosis compositions and methods of treating or preventing tuberculosis | |
| IL272121A (en) | Preparation and methods for the treatment of myopia | |
| IL289758B1 (en) | Proportin inhibitors for use in the prevention and treatment of kidney injury | |
| IL275875A (en) | Treatment and prevention of sleep disorders | |
| WO2016134257A8 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | |
| SG11202107687VA (en) | Prebiotic composition and its use | |
| IL270070B1 (en) | Compounds, compositions and methods for treating or preventing acute lung injury | |
| EP3848032A4 (en) | APPLICATION OF PYRROLOQUINOLINE QUINONE IN THE PREPARATION OF A MEDICINE USED FOR PREVENTING AND TREATING ACUTE ALTITUDE SICKNESS AND ACUTE ALTITUDE HYPOXIC INJURY | |
| PL3823623T3 (pl) | Podstawiony związek aminopirymidynowy do zastosowania w metodzie leczenia i zapobiegania stwardnieniu rozsianemu | |
| IL280218A (en) | Methods for the treatment of HFPEF using dapagliflozin and compounds containing it | |
| IL281559A (en) | A carbamate compound and use of a formulation containing it for the prevention, relief or treatment of major stress disorder or post-traumatic stress disorder | |
| PL3541185T3 (pl) | Zastosowanie 2-hydroksybenzyloaminy w leczeniu i zapobieganiu nadciśnieniu płucnemu | |
| ZA201905343B (en) | Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition | |
| ZA202100166B (en) | Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof | |
| PL3585422T3 (pl) | Kompozycja antyseptyczna zawierająca unitiol i dimetylosulfotlenek, zastosowanie kompozycji oraz sposób leczenia ran z jej zastosowaniem | |
| EP3501493A4 (en) | ANTI-WRINKLE COSMETIC COMPOSITION, USE OF THE COMPOSITION, ANTI-WRINKLE TREATMENT METHOD AND APPLICATION DEVICE | |
| IL259395B (en) | A cosmetic compound for use in the treatment and prevention of skin with acne | |
| EP3501492A4 (en) | COSMETIC COMPOSITION AGAINST SKIN Flaws, USE OF THE COMPOSITION, METHOD FOR TREATMENT AGAINST SKIN Flaws, AND APPLICATION DEVICE | |
| EP3501494A4 (en) | ANTI-WRINKLE COSMETIC COMPOSITION, USE OF THIS COMPOSITION AND ANTI-WRINKLE TREATMENT METHOD | |
| GB2589961B (en) | Deo emulsion for roll-on deodorant with antibacterial action, deodorant comprising the same and use of the deodorant | |
| HK40029532A (en) | Sleep disorder compositions and treatments thereof | |
| AU2017904818A0 (en) | Sleep Disorder Compositions and Treatments Thereof |